DE623495C - - Google Patents
Info
- Publication number
- DE623495C DE623495C DENDAT623495D DE623495DC DE623495C DE 623495 C DE623495 C DE 623495C DE NDAT623495 D DENDAT623495 D DE NDAT623495D DE 623495D C DE623495D C DE 623495DC DE 623495 C DE623495 C DE 623495C
- Authority
- DE
- Germany
- Prior art keywords
- hexamethylenetetramine
- salts
- compound
- rhodan
- calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- VKYKSIONXSXAKP-UHFFFAOYSA-N hexamethylenetetramine Chemical compound C1N(C2)CN3CN1CN2C3 VKYKSIONXSXAKP-UHFFFAOYSA-N 0.000 claims description 20
- 239000004312 hexamethylene tetramine Substances 0.000 claims description 10
- 235000010299 hexamethylene tetramine Nutrition 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 8
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 8
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- NJYFRQQXXXRJHK-UHFFFAOYSA-N (4-aminophenyl) thiocyanate Chemical class NC1=CC=C(SC#N)C=C1 NJYFRQQXXXRJHK-UHFFFAOYSA-N 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- ZMZDMBWJUHKJPS-UHFFFAOYSA-M Thiocyanate anion Chemical compound [S-]C#N ZMZDMBWJUHKJPS-UHFFFAOYSA-M 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000001476 alcoholic effect Effects 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 159000000007 calcium salts Chemical class 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- ALWXETURCOIGIZ-UHFFFAOYSA-N 1-nitropropylbenzene Chemical compound CCC([N+]([O-])=O)C1=CC=CC=C1 ALWXETURCOIGIZ-UHFFFAOYSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 description 2
- -1 Rhodan compound Chemical class 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000000645 desinfectant Substances 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- RLDQYSHDFVSAPL-UHFFFAOYSA-L calcium;dithiocyanate Chemical compound [Ca+2].[S-]C#N.[S-]C#N RLDQYSHDFVSAPL-UHFFFAOYSA-L 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000003578 releasing effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 150000003283 rhodium Chemical class 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/18—Bridged systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE623495C true DE623495C (enrdf_load_stackoverflow) |
Family
ID=576467
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DENDAT623495D Active DE623495C (enrdf_load_stackoverflow) |
Country Status (1)
| Country | Link |
|---|---|
| DE (1) | DE623495C (enrdf_load_stackoverflow) |
-
0
- DE DENDAT623495D patent/DE623495C/de active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2043933B2 (de) | N-(beta-naphthylaminomethyl)-aminocarbonsaeuren sowie diese enthaltende arzneimittel | |
| DE1445186C3 (de) | 3,3'-Di-2-imidazolin-2-yl-carbanilid | |
| DE623495C (enrdf_load_stackoverflow) | ||
| DE2515594C3 (de) | Verfahren zur Herstellung eines stabilen, topisch aktiven Geles | |
| DE1617524A1 (de) | Stabile,nichttoxische,kampferhaltige Lotion fuer therapeutische Zwecke und Verfahren zu ihrer Herstellung | |
| DE1695855C3 (de) | 4-(5-Isobutyl-2-pyrimidinyl)-sulfonamidophenylessigsäure-(2-methoxy-5chloranilid) und dessen Salze mit physiologisch verträglichen Basen | |
| CH185278A (de) | Verfahren zur Herstellung einer therapeutisch wirksamen Verbindung des Hexamethylentetramins. | |
| DE1068701B (de) | Verfahren zur Herstellung von antibiotisch wirksamem Tetracyclinnatriumhexametaphosphat | |
| DE872947C (de) | Verfahren zur Herstellung basischer AEther, Thioaether und ihrer Salze | |
| DE3612086A1 (de) | Konservierte antacida-zubereitungen | |
| DE295736C (enrdf_load_stackoverflow) | ||
| AT222805B (de) | Verfahren zur Herstellung eines neuen Derivates des Antibiotikums Kanamycin | |
| DE969562C (de) | Verfahren zur Herstellung von Camphersulfonaten aromatischer Alkanolamine | |
| DE2241076B2 (de) | Tetracyclinkomplex und dessen Salze, Verfahren zu dessen Herstellung und diesen Komplex enthaltende pharmazeutische Zusammensetzungen | |
| DE819402C (de) | Verfahren zur Herstellung von Amino- bzw. Imino- Karbonsaeurederivaten | |
| DE749305C (de) | Verfahren zur Darstellung von ªÏ-Methylsulfonsaeuren von Tetrahydrochinolinbasen | |
| DE2006206A1 (de) | Substituierte Bis-benzimidazole | |
| DE752680C (de) | Anionenaustausch | |
| DE414854C (de) | Verfahren zur Herstellung von organischen Wismutverbindungen | |
| DE1695681C (de) | l,alpha,alpha Trimethyl 2 pipendylcarbi nol diphenylacetat, dessen Saureadditions salze und Verfahren zu deren Herstellung | |
| DE810027C (de) | Verfahren zur Herstellung eines neuartigen Abkoemmlings des ª‡-Phenylaethylalkohols | |
| DE394851C (de) | Verfahren zur Herstellung eines Salzes der Methylarsinsaeure | |
| AT240366B (de) | Verfahren zur Herstellung des neuen 2-Methyl-3-(2'-methyl-3'-chlor-phenyl)-chinazolons-(4) | |
| DE944953C (de) | Verfahren zur Herstellung eines aus dem Calciumsalz der Ca-AEthylen-diamintetraessigsaeure bestehenden Therapeutikums | |
| AT233554B (de) | Verfahren zur Herstellung neuer bicyclischer Aminoketone und deren Salze |